Authors

Latest:

Cost Versus Quality in Different Sites of Cancer Care

More oncology providers have shifted toward consolidation of practices to remain viable. In the last 4 years, 524 private practices have entered into agreements with or have been acquired by hospitals.

Zachary S. Morris, MD, PhD

Latest:

Combinations With RT May Improve Immunotherapy Response

One potential approach to improving the response to cancer immunotherapies is to combine such treatments with radiotherapy.

Zahi Mitri, MD

Latest:

Dr. Mitri Discusses the Promise of Trastuzumab Biosimilars

Zahi Mitri, MD, MS, assistant professor of medicine, Oregon Health and Science University, discusses the promise of trastuzumab (Herceptin) biosimilars.

Zahi Mitri, MD, MS

Latest:

HER2-low Breast Cancer: Practical Applications of ADC Therapy

Practical considerations for the sequencing or combination of novel antibody drug conjugates to optimize outcomes for patients with HER2-low breast cancer.

Zarah Dulce F. Lucas, MD

Latest:

From Bedside to Bench

Based on a current laboratory research project, Zarah Dulce F. Lucas, MD, discusses microRNAs and their potential to predict brain metastases in patients with triple-negative and HER2-positive breast cancer.

Zev A. Wainberg, MD

Zev A. Wainberg, MD, MSc, is a professor of medicine in the Department of Medicine at UCLA and co-director of the UCLA GI Oncology Program

Latest:

Ongoing Research to Watch in Advanced Gastric/GEJ Cancer

Yelena Y. Janjigian, MD, and Zev A. Wainberg, MD, discuss ongoing trials that could help refine the gastric/GEJ cancer treatment paradigm.

Zev A. Wainberg, MD, David Geffen School of Medicine at UCLA

Zev A. Wainberg, MD, UCLA Medical Center

Latest:

“GI Talk”: A Review of Data from the ASCO 2020 Virtual Meeting

Zev A. Wainberg, MD, UCLA School of Medicine

Zhaoming Wang, PhD

Latest:

Utility of Genome-Wide Association Studies in Pediatric Oncology

Zhaoming Wang, PhD, bioinformatics scientist, Department of Computational Biology, St. Jude Children’s Research Hospital, discusses the utility of genome-wide association studies in pediatric oncology.

Zhi Zhang Yang, MD

Latest:

Dr. Yang on the Efficacy of Immunotherapy in Follicular Lymphoma

Zhi Zhang Yang, MD, assistant professor of Medicine, Mayo Clinic, discusses the expression of LAG-3 defining exhaustion of intratumoral PD-1 antibodies and T cells and correlates poor outcomes in patients with follicular lymphoma.

Ziad Bakouny, MD, MSc

Latest:

Dr. Bakouny on Understanding the Biology of Translocation RCC

Ziad Bakouny, MD, MSc, discusses understanding the biology of translocation renal cell carcinoma.

Zofia Piotrowska, MD, Harvard Medical School

Zofia Piotrowska, MD, Massachusetts General Hospital Cancer Center

Latest:

Experts Discuss Management of Skin and Mouth TRAEs Associated With EGFR TKIs

Christine Lovly, MD, PhD, Jeanne G. Vaughn, NP, Kristina Lo, PharmD, BCOP, and Linda Ahn discuss how to approach treatment-related adverse effects of the skin and mouth associated with the use of EGFR TKIs.

Zofia Piotrowska, MD, MHS

Latest:

Balancing Safety and Efficacy With ADC-Based Therapies in Advanced EGFRm Non–Small Cell Lung Cancer

Panelists discuss how ADC-based therapies like dato-DXd offer superior efficacy compared with traditional chemotherapy options like docetaxel, while requiring careful monitoring for unique toxicities including ILD, stomatitis, and ocular effects.

Zozo Greenholz, RN, Rocky Mountain Cancer Centers

Zsofia K. Stadler, MD

Latest:

Dr. Stadler on the Utility of Germline Profiling for Targeted Interventions in Advanced Cancer

Zsofia K. Stadler, MD, discusses a study evaluating the clinical utility of germline mutation profiling of targeted therapeutic interventions in a pan-cancer patient population.

Anthony T. Nguyen, MD, PhD

Latest:

Dr Nguyen on the Role of Concurrent Chemotherapy With TMT in MIBC

Anthony T. Nguyen, MD, PhD, discusses the role of concurrent chemotherapy with trimodal therapy in patients with muscle-invasive bladder cancer.

Yvonne Mowery, MD, PhD

Latest:

Dr Mowery on Pembrolizumab Plus Radiation Therapy and Surgery in Soft Tissue Sarcoma

Yvonne Mowery, MD, PhD, discusses the SU2C-SARC032 trial of pembrolizumab plus radiotherapy followed by surgery in soft tissue sarcoma.

Rita Mukhtar, MD

Latest:

Dr Mukhtar on Recurrence Risk in Invasive Lobular Carcinoma

Rita Mukhtar, MD, discusses the risk of disease recurrence in patients with invasive lobular carcinoma.